TXA127 (Angiotensin 1-7)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TXA127 (Angiotensin 1-7), covering 2016-08-31 to 2016-08-31. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation [Phase 2]